Swiss pharmaceutical company Novartis envisions a world where access to healthcare is not a privilege but a fundamental human right, and this vision drives its global health initiatives.

Switzerland-based Novartis has one of the strongest and broadest portfolios of varied drugs that has enabled it to maintain its dominant position as a top pharma company over the years.

This article was coproduced with Kody Kester. Since last October, Novartis' shares have lagged the S&P 500 index. The pharmaceutical company's pipeline remains robust, which could translate into ...

The National Football League (NFL) announced Novartis as its first-ever corporate pharmaceutical partner on March 13.